WinstonWınston
Back
Stock

Ansell Limited

ANSLY
55
Medical - Instruments & Supplies · Healthcare
Price
$81.94
-25.90 (-24.02%)
Market Cap
$2.88B
Exchange
Other OTC
Winston Score
55
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Sep 19, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Good
Growth
Good
Cash Flow
Exceptional
Stability
Strong
Valuation
Good
Dividends
Exceptional
Track this stock — start free trial

Share count rising — dilution

+12.2% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 32.0M (2022) → 36.0M (2026)

§Winston Score History

The full picture

Ansell is an Australian company that makes protective gloves and body protection products. Its two main business segments are healthcare and industrial, supplying surgical gloves, exam gloves, and chemical-resistant gloves to hospitals, laboratories, factories, and workers in hazardous environments. It is one of the largest protective glove manufacturers in the world.

Ansell earns revenue by selling its products to distributors, hospitals, and industrial customers across more than 100 countries. Manufacturing is spread across Asia, Europe, and the Americas, helping keep costs competitive. The company's scale, global distribution network, and strong brand recognition in safety products give it a durable market position. A key growth driver is rising workplace safety regulations worldwide, though Ansell faces ongoing risk from raw material price swings and competition from lower-cost manufacturers.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+13.6% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+165.6% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$22M/ year

↑ Rising (+5% vs prior year)

1.0% of revenue

Below sector average (18%)

R&D investment increasing — building for the future

Insider Activity

0.0%ownership

Relatively low insider ownership

Cash Position

Cash flow positive

$254M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Ansell Limited is a rare growth stock that's already generating positive cash flow while growing at 14%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
41.8%
Healthy — 41.8% gross margin
Profit after running costs
Operating Margin
15.7%
Healthy — 15.7% operating margin
Return on the money invested
ROCE
11.5%
Below par — 11.5% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+7.1%
Steady sales growth (+7.1% YoY)
Profit growth
EPS YoY
+110.0%
Earnings growing fast (+110.0% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
167%
Turns 167% of profit into real cash
Spare cash per sale
FCF Margin
14.0%
Converts sales into free cash efficiently (14.0%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.38
Conservative — low debt load (0.38)
Covers its interest
Interest Cover
6.96x
Adequate interest coverage (7.0x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
13.9x
Attractive valuation — P/E 13.9

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
-3.3
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
4.05%
Healthy income — 4.05% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record
Dividend Growth
+40.3%
Dividend growing fast (40.3% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial